Local tissue factor pathway inhibitor release in the human forearm

Area of Science:

• Vascular Biology
• Pharmacology
• Hemostasis

Background:

• Tissue Factor Pathway Inhibitor (TFPI) plays a crucial role in regulating the coagulation cascade.
• Understanding regional differences in TFPI release is important for targeted anticoagulant therapies.

Purpose of the Study:

• To investigate the effect of unfractionated heparin on TFPI release in the human forearm circulation.
• To compare the forearm's sensitivity to heparin-induced TFPI release with systemic circulation.
• To examine the impact of vasodilators (substance P, bradykinin) and an endothelium-independent vasodilator (sodium nitroprusside) on TFPI levels and blood flow.

Main Methods:

• Unilateral brachial artery infusions of unfractionated heparin, substance P, bradykinin, and sodium nitroprusside in healthy men.
• Measurement of plasma TFPI concentrations and forearm blood flow.
• Statistical analysis using ANOVA and t-tests to determine dose-dependency and significant differences.

Main Results:

• Heparin caused a dose-dependent increase in plasma TFPI concentrations in both infused and contralateral arms.
• Forearm TFPI release in response to heparin was significantly lower compared to systemic circulation, indicating reduced sensitivity.
• Substance P, bradykinin, and sodium nitroprusside increased blood flow dose-dependently but did not affect plasma TFPI concentrations.

Conclusions:

• The forearm circulation exhibits regional differences in endothelial TFPI release, being relatively insensitive to heparin.
• Heparin's anticoagulant effects may vary regionally due to differential TFPI release.
• Vasodilators do not appear to influence TFPI release in the forearm circulation.